Pseudotransduction of hepatocytes by using concentrated pseudotyped vesicular stomatitis virus G glycoprotein (VSV-G)-moloney murine leukemia virus-derived retrovirus vectors: Comparison of VSV-G and amphotropic vectors for hepatic gene transfer

Journal of Virology

Volumn 70, Issue 4, 1996, Pages 2497-2502

  Liu, Miao Liang ^a   Winther, Brian L ^a   Kay, Mark A ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; BETA GALACTOSIDASE; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ESCHERICHIA COLI; FEMALE; GENE TRANSFER; GENETIC TRANSDUCTION; LIVER CELL CULTURE; MOLONEY LEUKEMIA ONCOVIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; RETROVIRUS; VESICULAR STOMATITIS VIRUS; VIRUS TYPING;

3T3 CELLS; ANIMALS; BETA-GALACTOSIDASE; CELL LINE; CELLS, CULTURED; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; LIVER; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MOLONEY MURINE LEUKEMIA VIRUS; RATS; VIRAL ENVELOPE PROTEINS;

EID: 0029931982     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.4.2497-2502.1996     Document Type: Article

References (23)

1. Burns, J. C., T. Friedmann, W. Driever, D. Wolfgang, M. Burrascano, and J.-K. Yee. 1993. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc. Natl Acad. Sci. USA 90: 8033-8037.
2. Fassati, A., D. J. Wells, F. S. Walsh, and G. Dickson. 1995. Efficiency of in vivo gene transfer using murine retroviral vectors is strain-dependent in mice. Hum. Gene Ther. 6:1177-1183.
3. Friedmann, T., L. Xu, J. Wolff, J.-K. Yee, and A. Miyanohara. 1989 Retrovirus vector-mediated gene transfer into hepatocytes. Mol. Biol Med. 6: 17-125.
4. Grompe, M., S. Jones, H. Loulseged, and T. Caskey. 1992 Retroviral-medi-ated gene transfer of human ornithine transcarbamylase into primary hepatocytes of spf and spf-ash mice. Hum. Gene Ther. 3:35-44.
5. 4a.Kay, M. A. Unpublished data
6. Kay, M. A., Q. Li, T. J. Liu, F. Leland, C. Toman, M. Finegold, and S. L. Woo. 1992. Hepatic gene therapy: persistent expression of human alpha 1-antitrypsin in mice after direct gene delivery in vivo. Hum. Gene Ther. 3: 641-647.
7. Kay, M. A., S. Rothenberg, C. N. Landen, D. A. Bellinger, F. Leland, C. Toman, M. Finegold, A. R. Thompson, M. S. Read, K. M. Brinkhous, and S. L. C. Woo. 1993. In vivo gene therapy of hemophilia B: sustained partial correction in factor IX-deficient dogs. Science 262:117-119.
8. Ledley, F. D., G. J. Darlington, T. Hahn, and S. L. C. Woo. 1987. Retroviral gene transfer into primary hepatocytes: implications for genetic therapy of liver-specific functions. Proc. Natl. Acad. Sci. USA 84:5335-5339.
9. Lieber, A., M. J. T. F. D. Vrancken Peeters, A. Gown, J. Perkins, and M. A. Kay. 1995. A modified urokinase plasminogen activator induces liver regeneration without bleeding. Hum. Gene Ther. 6:1029-1037.
10. Lieber, A., M. J. T. F. D. Vrancken Peeters, L. Meuse, N. Fausto, J. Perkins, and M. A. Kay. 1995. Adenovirus-mediated urokinase gene transfer induces liver regeneration and allows for efficient retrovirus transduction of hepatocytes in vivo. Proc. Natl. Acad. Sci. USA 92:6210-6214.
11. Liu, T. J., M. A. Kay, G. J. Darlington, and S. L. C. Woo. 1992 Reconstitution of enzymatic activity in hepatocytes of phenylalanine hydroxylase-deficient mice. Somatic Cell Mol. Genet. 18:89-96.
12. MacGregor, G. R. 1989. Use of E. coli lacZ as a reporter gene. Methods Mol Biol. 7:1-19.
13. Miyanohara, A., J.-K. Yee, K. Bouic, P. LaPorte, and T. Friedmann. 1995. Efficient in vivo transduction of the neonatal mouse liver with pseudotyped retroviral vectors. Gene Ther. 2:138-142.
14. Pages, J. C., M. Andreoletti, M. Bennoun, C. Vons, J. Elcheroth, P. Lehn, D. Houssin, J. Chapman, P. Briand, and R. E. A. Benarous. 1995. Efficient retroviral-mediated gene transfer into primary culture of murine and human hepatocytes' expression of the LDL receptor. Hum. Gene Ther. 6:21-30.
15. Ponder, K. P., R. P. Dunbar, D. R. Wilson, G. J. Darlington, and S. L. C. Woo. 1991. Evaluation of relative promoter strength in primary hepatocytes using optimized lipofection. Hum. Gene Ther. 2:41-52.
16. Ponder, K. P., S. Gupta, F. Leland, G. Darlington, M. Finegold, J. DeMayo, F. Ledley, J. R. Chowdhury, and S. L. C. Woo. 1991 Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation. Proc. Natl. Acad. Sci. USA 88:1217-1221.
17. Rother, R. P., S. P. Squinto, J. M. Mason, and S. A. Rollins. 1995 Protection of retroviral vector particles in human blood. Hum. Gene Ther 6:429-435.
18. Takeuchi, Y., F. L. Cosset, P. J. Lachmann, H. Okada, R. A. Weiss, and M. K. Collins. 1994. Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell J Virol. 68: 8001-8007.
19. Vrancken Peeters, M. J. T. F. D., A. Lieber, J. Perkins, and M. A. Kay. A method for multiple portal vein infusions in mice: quantitation of adenovirus-mediated hepatic gene transfer. BioTechniques, in press.
20. Wilson, J. M., D. M. Jefferson, J. R. Chowdhury, P. M. Novikoff, D. E. Johnston, and R. C. Mulligan. 1988. Retrovirus-mediated transduction of adult hepatocytes. Proc. Natl. Acad. Sci. USA 85:3014-3018.
21. Yang, Y., E. F. Vanin, M. A. Whitt, M. Fornerod, R. Zwart, R. D. Schneiderman, G. Grosveld, and A. W. Nienhuis. 1995. Inducible, high level production of infectious murine leukemia retroviral vector particles pseudo typed with vesicular stomatitis virus G envelope protein. Hum Gene Ther. 6:1203-1213.
22. Yee, J.-K., T. Friedmann, and J. Burns. 1994. Generation of high-titer pseudotyped retroviral vectors with very broad host range. Methods Cell Biol. 43:99-112.
23. Yee, J.-K., A. Miyanohara, P. LaPorte, K. Bouic, J. Burns, and T. Friedmann. 1994. A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes. Proc. Natl. Acad. Sci. USA 91:9564-9568.